The worldwide distribution of the VHL 598C>T mutation indicates a single founding event

被引:60
作者
Liu, EL
Percy, MJ
Amos, CI
Guan, YL
Shete, S
Stockton, DW
McMullin, MF
Polyakova, LA
Ang, SO
Pastore, YD
Jedlickova, K
Lappin, TRJ
Gordeuk, V
Prchal, JT
机构
[1] Baylor Coll Med, Hematol Oncol Sect, Houston, TX 77030 USA
[2] Vet Affairs Med Ctr, Houston, TX 77030 USA
[3] Belfast City Hosp, Belfast BT9 7AD, Antrim, North Ireland
[4] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Queens Univ Belfast, Belfast, Antrim, North Ireland
[6] Chuvash Republ Clin Hosp 1, Cheboksary, Russia
[7] Howard Univ, Washington, DC 20059 USA
关键词
D O I
10.1182/blood-2003-07-2550
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The first congenital defect of hypoxia-sensing homozygosity for VHL 598C>T mutation was recently identified in Chuvash polycythemia. Subsequently, we found this mutation in 11 unrelated individuals of diverse ethnic backgrounds. To address the question of whether the VHL 598C>T substitution occurred in a single founder or resulted from recurrent mutational events in human evolution, we performed haplotype analysis of 8 polymorphic markers covering 340 kb spanning the VHL gene on 101 subjects bearing the VHL 598C>T mutation, including 72 homozygotes (61 Chuvash and 11 non-Chuvash) and 29 heterozygotes (11 Chuvash and 18 non-Chuvash), and 447 healthy unrelated individuals from Chuvash and other ethnic groups. The differences in allele frequencies for each of the 8 markers between 447 healthy controls (598C) and 101 subjects bearing the 598T allele (p < 10(-7)) showed strong linkage disequilibrium. Haplotype analysis indicated a founder effect. We conclude that the VHL 598C>T mutation, the most common defect of congenital polycythemia yet found, was spread from a single founder 14 000 to 62 000 years ago. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:1937 / 1940
页数:4
相关论文
共 18 条
[1]   Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia [J].
Ang, SO ;
Chen, H ;
Hirota, K ;
Gordeuk, VR ;
Jelinek, J ;
Guan, YL ;
Liu, EL ;
Sergueeva, AI ;
Miasnikova, GY ;
Mole, D ;
Maxwell, PH ;
Stockton, DW ;
Semenza, GL ;
Prchal, JT .
NATURE GENETICS, 2002, 32 (04) :614-621
[2]   Endemic polycythemia in Russia: Mutation in the VHL gene [J].
Ang, SO ;
Chen, H ;
Gordeuk, VR ;
Sergueeva, AI ;
Polyakova, LA ;
Miasnikova, GY ;
Kralovics, R ;
Stockton, DW ;
Prchal, JT .
BLOOD CELLS MOLECULES AND DISEASES, 2002, 28 (01) :57-62
[3]  
CROSSEY PA, 1994, HUM MOL GENET, V3, P1303
[4]  
EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921
[5]  
Kruglyak L, 1996, AM J HUM GENET, V58, P1347
[6]   HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis:: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression [J].
Laughner, E ;
Taghavi, P ;
Chiles, K ;
Mahon, PC ;
Semenza, GL .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (12) :3995-4004
[7]   Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered? [J].
Luttun, A ;
Carmeliet, P .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) :600-602
[8]   Haplotype analysis in population-based association studies [J].
Mander, A. P. .
STATA JOURNAL, 2001, 1 (01) :58-75
[9]   The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis [J].
Maxwell, PH ;
Wiesener, MS ;
Chang, GW ;
Clifford, SC ;
Vaux, EC ;
Cockman, ME ;
Wykoff, CC ;
Pugh, CW ;
Maher, ER ;
Ratcliffe, PJ .
NATURE, 1999, 399 (6733) :271-275
[10]   Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia [J].
Pastore, Y ;
Jedlickova, K ;
Guan, YL ;
Liu, EL ;
Fahner, J ;
Hasle, H ;
Prchal, JF ;
Prchal, JT .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (02) :412-419